Scoop: Resonance Medicine, a protease biotech from David Liu’s lab, shuts down

Res­o­nance Med­i­cine, a two-year-old stealth-stage biotech out of the lab of famed bio­chemist David Liu, has de­cid­ed to shut down, End­points News has learned.

The biotech, backed by some of the in­dus­try’s most promi­nent in­vestors, de­cid­ed to shut down be­cause the sci­ence was too nascent, a source fa­mil­iar with the mat­ter told End­points on Tues­day. Fi­nanc­ing, which has been hard to come by in the cur­rent biotech en­vi­ron­ment, was not a rea­son, the source not­ed, ask­ing not to be iden­ti­fied.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.